We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients (RBV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00993122
Recruitment Status : Completed
First Posted : October 12, 2009
Last Update Posted : June 22, 2015
Information provided by (Responsible Party):
Manuela Merli, University of Roma La Sapienza

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2010
  Study Completion Date : February 2012